Company Presentation

Phialogics AG

Category:Emerging Biotech Company
Date:April 23, 2024
Time:14:45 – 15:00
Speaker:Andreas Ernst, CEO / CSO

Company profile

Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.
Phialogics concept is based on the targeted modification of immunoglobulin receptor domains (IgVs) to modulate immune response in inflammatory diseases.

Follow us